● Recruiting

HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata

Condition: Alopecia Areata(AA) · Sponsor: HCW Biologics

PhasePhase 1

Planned participants30

Who can joinAll sexes, 18 Years to 70 Years

Healthy volunteersNo

About this study

This is a Phase 1, open-label, multi-center, competitive enrollment, and dose-escalation study of HCW9302 in subjects with Alopecia Areata (AA)

This description comes directly from the study's public registry record.

Talk to the study team

Pallavi Chaturvedi, PhD. · 19548422024 · clinical@hcwbiologics.com

Always discuss trial participation with your own doctor first.

Locations (2)

James A. Haley Veterans' Hospital	Tampa, Florida, United States	Recruiting
The Ohio State University Wexner Medical Center	Columbus, Ohio, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07049328